Bacteria-induced susceptibility to Candida albicans super-infection in mice via monocyte methyltransferase Setdb2

Cellular Microbiology
Xiao-Ping ChenJin-Xing Lu

Abstract

Systemic bacterial infections are prone to secondary Candida albicans super-infection. However, the molecular mechanisms involved remain poorly understood. In this study, a model comprising sublethal cecal ligation and puncture plus C. albicans intravenous injection was applied to mimic the situation in super-infection. Compared with mice without systemic bacterial infection, mice with systemic bacterial infection had lower antifungal gene expression (including Il1b, Tnf, Il6, Ifnb, Ifng, Cxcl1, and Ccr2) in monocytes and less inflammatory monocytes and neutrophils infiltrating into the kidney when challenged with C. albicans. Further, lentivirus-mediated Setdb2-knockout and overexpression experiments verified that Setdb2 levels in monocytes correlated negatively with antifungal gene expression and survival rates. Transcriptional repression was probably achieved by Setdb2 through H3 methylation at lysine 9 in promoter regions of these antifungal genes.

References

Jan 10, 2003·The New England Journal of Medicine·Richard S Hotchkiss, Irene E Karl
Dec 12, 2003·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Kai Singbartl, Klaus Ley
Aug 10, 2005·Genome Biology·Shane C DillonXiaodong Cheng
Feb 27, 2007·Cell·Tony Kouzarides
Mar 1, 2007·Current Opinion in Critical Care·Stijn I BlotJan J De Waele
Jun 1, 2007·Nature·Simmie L FosterRuslan Medzhitov
Nov 21, 2008·Clinical and Vaccine Immunology : CVI·Xiaoping ChenCharles E McCall
Mar 6, 2009·Genome Biology·Ben LangmeadSteven L Salzberg
Dec 23, 2009·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·E S MeloF G Soriano
Feb 2, 2010·Cell Host & Microbe·Gordon D Brown
Sep 10, 2010·Biology of Reproduction·Cathryn A HogarthMichael Griswold
Oct 20, 2010·Expert Review of Anti-infective Therapy·Guillaume Monneret, Fabienne Venet
Nov 11, 2010·Journal of Innate Immunity·Michail S LionakisPhilip M Murphy
May 14, 2011·Chemical Biology & Drug Design·Victoria M RichonRobert A Copeland
Mar 1, 2012·Science·Ruslan MedzhitovMiguel P Soares
Mar 14, 2012·The Journal of Experimental Medicine·Terry C FangAlexander Tarakhovsky
Mar 16, 2012·Nature·Ivan MarazziAlexander Tarakhovsky
Jun 14, 2012·The Journal of Infectious Diseases·Jacqueline UnsingerRichard S Hotchkiss
Dec 5, 2012·Cold Spring Harbor Perspectives in Medicine·Hélène BiernePascale Cossart
Jul 5, 2013·Methods in Molecular Biology·Donna M MacCallum
Aug 3, 2013·Science·Haig A EskandarianMélanie A Hamon
Aug 8, 2013·The Journal of Infectious Diseases·Lisa Y NgoTobias M Hohl
Mar 10, 2015·Nature Methods·Daehwan KimSteven L Salzberg
Sep 16, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Evan L ChiswickDaniel G Remick
Sep 25, 2015·The FEBS Journal·Simon M CarrNicholas B La Thangue
Sep 30, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Noelia Blanco-MenéndezDavid Sancho
Oct 4, 2017·Critical Reviews in Microbiology·Aleksander M Grabiec, Jan Potempa

❮ Previous
Next ❯

Citations

May 24, 2019·Pathogens·Wibke KrügerMaria Joanna Niemiec

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.